Sandra Scheuer
Affiliations: | 2014-2018 | Max Planck Institute for Psychiatry Munich |
Google:
"Sandra Scheuer"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ising M, Maccarrone G, Brückl T, et al. (2019) FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. International Journal of Molecular Sciences. 20 |
| Ising M, Scheuer S, Belcredi P, et al. (2019) Perspective of personalised drug treatment in depression European Neuropsychopharmacology. 29: S46-S47 |
| Breitenstein B, Scheuer S, Brückl TM, et al. (2015) Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. Journal of Psychiatric Research. 73: 86-95 |
| Scheuer S, Ising M, Uhr M, et al. (2015) FKBP5 polymorphisms moderate the influence of adverse life events on the risk of anxiety and depressive disorders in preschool children. Journal of Psychiatric Research. 72: 30-36 |
| White LO, Klein AM, Kirschbaum C, et al. (2015) Analyzing pathways from childhood maltreatment to internalizing symptoms and disorders in children and adolescents (AMIS): a study protocol. Bmc Psychiatry. 15: 126 |
| Breitenstein B, Scheuer S, Holsboer F. (2014) Are there meaningful biomarkers of treatment response for depression? Drug Discovery Today. 19: 539-61 |
| Breitenstein B, Scheuer S, Pfister H, et al. (2014) The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. Cns Spectrums. 19: 165-75 |
| Breitenstein B, Scheuer S, Pfister H, et al. (2012) P.2.a.004 The clinical utility of ABCB1 genotyping in antidepressant treatment European Neuropsychopharmacology. 22 |
| Breitenstein B, Scheuer S, Pfister H, et al. (2012) P.1.a.004 CRHR1 and ABCB1 modulate sleep disturbance in depression European Neuropsychopharmacology. 22 |